Casa Sollievo della Sofferenza is a private scientific research hospital in San Giovanni Rotondo, Italy, founded by Saint Pio of Pietrelcina, and administered by Vatican City.

During the past decade, Ente Ecclesiastico Casa Sollievo Della Sofferenza - San Giovanni Rotondo - Ematologia conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ente Ecclesiastico Casa Sollievo Della Sofferenza - San Giovanni Rotondo - Ematologia" #1 collaborator was "CML Advocates Network" with 1 trials as a collaborator, "European Leukemia Net" with 1 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator and "Hematology Project Foundation" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Ente Ecclesiastico Casa Sollievo Della Sofferenza - San Giovanni Rotondo - Ematologia" are "Acute Myeloid Leukemia" (4 trials), "Chronic Myeloid Leukemia" (3 trials), "Philadelphia-Positive ALL" (2 trials), "ALL, Adult" (1 trials) and "AML, Adult" (1 trials). Many other conditions were trialed in "Ente Ecclesiastico Casa Sollievo Della Sofferenza - San Giovanni Rotondo - Ematologia" in a lesser frequency.

Most popular intervention types in "Ente Ecclesiastico Casa Sollievo Della Sofferenza - San Giovanni Rotondo - Ematologia" are "Drug" (7 trials), "Other" (5 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ponatinib" (2 trials), "Arsenic Trioxide" (1 trials), "Chemotherapy" (1 trials), "Chemotherapy + Imatinib" (1 trials) and "Gemtuzumab Ozogamicin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ente Ecclesiastico Casa Sollievo Della Sofferenza - San Giovanni Rotondo - Ematologia" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Ente Ecclesiastico Casa Sollievo Della Sofferenza - San Giovanni Rotondo - Ematologia". undefined are not yet recruiting, 10 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Ente Ecclesiastico Casa Sollievo Della Sofferenza - San Giovanni Rotondo - Ematologia, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ente Ecclesiastico Casa Sollievo Della Sofferenza - San Giovanni Rotondo - Ematologia, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".